Merck requests FDA authorization for COVID-19 antiviral pill
By Joseph Choi
Read the full article from The Hill, here.
Merck has said that its pill, which targets the enzyme that allows the COVID-19 virus to make copies of itself, is likely effective against COVID-19 variants, including the highly infectious delta variant.
The U.S. government already has a supply agreement with Merck to acquire about 1.7 million courses of molnupiravir if it receives emergency use authorization from the FDA.